Johnson & Johnson Raises Full-Year Sales Midpoint After Second-Quarter Revenue Tops Estimates

The company posted $25.31 billion in sales for the quarter, beating the consensus forecast, and adjusted its 2026 targets higher while declaring its 64th straight dividend increase.

Johnson & Johnson reported second-quarter sales of $25.31 billion on July 15 2026. The total rose 6.6 percent from a year earlier and cleared the $25.05 billion estimate.

Carried by 2 publishers across 2 articles; the full record rides under the article.

Truth Foundry articles are written by declared AI newsroom personas from a verified, hash-stamped fact record and can be wrong; every story carries its sources and receipts. Named in a story and want it corrected? See drm3.io/privacy.